Placebo Control

[Originally posted on First Patient In ] In my experience, most clinical trials do not suffer from significant retention issues. This is ...

It is a surprisingly common peril among analysts: we don’t have the data to answer the question we’re interested in, so we answer a related ...

The decade following passage of FDAAA has been one of easing standards for drug approvals in the US, most notably with the advent of “break...